References
- Annuk M, Zilmer M, Fellstrom B. 2003. Endothelium dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease. Kid Int. 63(84):S50–S53.
- Anupama YJ, Uma G. 2014. Prevalence of chronic kidney disease among adults in a rural community in South India: results from the kidney disease screening [KIDS] project. Ind J Nephrol. 24(4):214–221.
- Bruno RM, Di Pilla M, Ancona C, Sørensen M, Gesi M, Taddei S, Munzel T, Virdis A. 2017. Environmental factors and hypertension. Curr Pharm Des. 23(22):3239–3246.
- Byrne C, Nedelman J, Luke RG. 1994. Race, socioeconomic status and the development of end-stage renal disease. Am J Kidney Dis. 23(1):16–22.
- Cachofeiro V, Goicochea M, de Vinuesa SG, Oubin P, Lahera V, Lun J. 2008. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 74:S4–S9.
- Draper HH, Csallany AS, Hadley M. 2000. Urinary aldehydes as indicators of lipid peroxidation in vivo. Free Radic Biol Med. 29(11):1071–1077.
- Draper HH, Hadley M. 1990. Malondialdehyde determination as an index of lipid peroxidation. Methods Enzymol. 186:421–431.
- Flohe L, Gunzle A. 1972. Assay of glutathione peroxidase. Methods Enzymol. 105:114–121.
- Govil PK, Sorlie JE, Sujatha D, Keshav Krishna A, Murthy NN, Rama Mohan K. 2012. Assessment of heavy metal pollution in lake sediments of Katedan industrial development area, Hyderabad, India. Environ Earth Sci. 2012(66):121–128.
- Grossman E. 2008. Does increased oxidative stress cause hypertension? Diabetes Care. 2S:185–189.
- Indian Council for Medical Research (ICMR). 1990. Nutrient requirement and recommended dietary allowances for Indians. Indian Council of Medical Research. Hyderabad (India): National Institute of Nutrition.
- Jha V. 2013. Current status of end-stage renal disease care in India and Pakistan. Kid Int Suppl. 3(2):157–160.
- Kakkar PS, Das B, Viswanathan PN. 1984. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 21:130–132.
- Ketteler M, Ritz E. 2000. Renal failure: a state of nitric oxide deficiency? Kidney Int. 58(3):1356–1357.
- Kisic B, Miric D, Stolic R, Ilic A, Rasic J, Miric M, Dragojevic I. 2014. Investigation of lipid peroxidation products and antioxidant enzyme activities in end-stage renal disease patients. Adv Chem Eng Sci. 4(1):73–80.
- Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. 1996. Blood pressure and end-stage renal disease in men. N Engl J Med. 334(1):13–18.
- Krishna AK, Mohan KR. 2014. Risk assessment of heavy metals and their source distribution in waters of a contaminated industrial site. Environ Sci Pollut Res. 21:3653–3669.
- Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanners C, Zoccali C. 2003. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 18(7):1272–1280.
- Luft FC. 2000. Hypertensive nephrosclerosis – a cause of end-stage renal disease? Nephrol Dial Transplant. 15(10):1515–1517.
- Luke RG. 1999. Hypertensive nephrosclerosis: pathogenesis and prevalence. Nephrol Dial Transplant. 14(10):2271–2278.
- Miranda KM, Espey MG, Wink DA. 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 5(1):62–71.
- Nie J, Hou FF. 2008. Role of reactive oxygen species in the renal fibrosis. Chin Med J [Engl]. 125(14):2598–2602.
- Pastore A, Federici G, Bertini E, Piemonte F. 2003. Analysis of glutathione: implication in oxidative and detoxification. Clin Chim Acta. 333(1):19–39.
- Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, Gang S, Gupta A, Modi G, Pahari D, et al. 2012. What do we know about chronic kidney disease in India: first report of the Indian CKD registry? BMC Nephro. 13:10.
- Raju DSSK, Lalitha DL, Kiranmayi P. 2013. A study of lipid profile and lipid peroxidation in chronic kidney disease with special reference to hemodialysis. J Clinic Res Bioeth. 4:143.
- Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bachler JP. 2007. Relationship between oxidative stress and essential hypertension. Hypertens Res. 30(12):1159–1167.
- Schmidt RJ, Baylis C. 2000. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int. 58(3):1261–1266.
- Sinha AK. 1972. Colorimetric assay of catalase. Anal Biochem. 47:389–394.
- Thomas G, Skrinska V. 1995. Determination of glutathione in human platelets. Clin Chem. 31:350–351.
- Tipple TE, Rogers LK. 2012. Methods for the determination of plasma or tissue glutathione levels. Methods Mol Biol. 889:315–324.
- Varma PP. 2015. Prevalence of chronic kidney disease in India. Where are we heading? Ind J Nephrol. 25(3):133–135.
- WHO. Guidelines for drinking water health criteria and other supporting information. World Health Organization, Geneva, 1996; 973.
- Wever R, Boer P, Hijmering M, Stores E, Verhaar M, Kastelein J, Versluis K, Lagerwerf F, van Rijn H, Koomans H, et al. 1999. Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol. 19(5):1168–1172.
- Yoshimura S, Suemizu H, Nomoto Y, Sakai H, Katsuoka Y, Kawamura N, Moriruchi T. 1996. Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron. 73(2):207–211.